An update on the efficacy and safety of aclidinium bromide in patients with COPD
Aclidinium is a potent and selective muscarinic antagonist, which interacts rapidly with muscarinic receptors and shows subnanomolar affinity for the five human muscarinic receptors (M 1 –M 5 ); its association rate for the M 3 receptor is similar to that of ipratropium and 2.6 times faster than tha...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2011-02-01
|
| Schriftenreihe: | Therapeutic Advances in Respiratory Disease |
| Online-Zugang: | https://doi.org/10.1177/1753465810381546 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|